Pharmacological Properties of Ficus Species

Ficus species, one of the largest genera in the Moraceae family, are rich in diverse phytoconstituents including flavonoids, terpenoids, phenolic acids, alkaloids and sterols. These bioactive compounds underpin a broad spectrum of pharmacological activities such as antioxidant, anti-inflammatory, antidiabetic, anticancer, antimicrobial, neuroprotective and hepatoprotective effects. Antioxidant activity arises from free-radical scavenging by phenolic and flavonoid components, while anti-inflammatory actions are mediated by inhibition of key enzymes and signalling pathways. Antidiabetic properties derive from suppression of carbohydrate-hydrolysing enzymes and modulation of insulin signalling cascades. Several species have demonstrated antineoplastic potential through antimitotic and antiproliferative mechanisms. Neuroprotective effects involve acetylcholinesterase inhibition and suppression of oxidative stress. Practical applications include development of natural therapeutics for metabolic disorders, inflammatory diseases, neurodegeneration and as lead structures for drug development. Recent advances in extraction techniques and nanoparticle formulations have enhanced bioavailability and targeted delivery, further broadening the translational scope of Ficus-derived agents.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Pharmacological Properties of Ficus Species publication trend

The graph below shows the total number of articles in pharmacological properties of ficus species across all publications each year (not limited to Nature Index journals).

Technical terms

Phytoconstituents: Bioactive chemical compounds produced by plants, such as flavonoids, terpenoids and alkaloids.

EGFR: Transmembrane receptor that regulates cell proliferation and inflammatory responses upon activation.

PI3K/Akt pathway: Intracellular signalling cascade involved in cell survival, metabolism and inflammation.

Acetylcholinesterase: Enzyme that hydrolyses the neurotransmitter acetylcholine, central to neural transmission.

α-Glucosidase: Enzyme catalysing carbohydrate breakdown, commonly targeted in antidiabetic therapy.

Cyclooxygenase-2 (COX-2): Inducible enzyme responsible for the production of pro-inflammatory prostaglandins.

5-Lipoxygenase (5-LOX): Enzyme catalysing leukotriene biosynthesis, contributing to inflammatory responses.

References

1. Phytochemistry, Pharmacological Properties, and Recent Applications of Ficus benghalensis and Ficus religiosa. Plants (2021).
2. A New EGFR Inhibitor from Ficus benghalensis Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition. Current Issues in Molecular Biology (2022).
3. In vitro antimitotic, antiproliferative and antioxidant activity of stem bark extracts of Ficus benghalensis L.. South African Journal of Botany (2017).
4. A pharmacological audit and advancement on the recent trend of research on Ficus benghalensis L. including its in vitro hepatoprotective activity. Clinical Phytoscience (2020).
5. In-vitro antioxidant potential and acetylcholinesterase inhibitory effect of Ficus benghalensis aerial root extract. African Health Sciences (2022).
6. Anti-Diabetic, Anti-Cholinesterase, and Anti-Inflammatory Potential of Plant Derived Extracts and Column Semi-Purified Fractions of Ficus benghalensis. Frontiers in Bioscience-Landmark (2024).